Atopic Dermatitis study: APG777
Official title A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
ClinicalTrials.gov ID: NCT07003425
What this study is testing
What is APG777?
APG777 is an investigational injectable medicine being studied as a potential treatment for moderate-to-severe atopic dermatitis.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to find out if the treatment is safe and effective over a longer period of time.
- Who it's for
- This study is for people with moderate-to-severe eczema who have already finished a previous study using this same treatment.
- What's involved
- Participants will continue receiving the treatment and visit the clinic for check-ups and tests to monitor their health and skin condition.
- Time commitment
- The study involves a screening visit, a period of extended treatment, and a follow-up period after treatment ends.
- Phase 2: a mid-size study of how well it works
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Participants who have completed the Treatment Period in a prior APG777 study and were, in the Investigator's opinion, compliant with the study...
- Participants who, in the Investigator's opinion, would benefit from long-term treatment with APG777
- Use the same non-prescription non-medicated emollient/moisturizer of their choice from the last day of the Parent Study and throughout the LTE study
You likely can't join if
- Participants who have developed an AE while participating in the Parent Study, which, in the opinion of the Investigator or of the Medical Monitor...
- Participants who terminated early from the Parent Study or permanently discontinued the study drug during the Parent Study
- Use of any of the prohibited medications from Screening Visit (Visit 1) of the LTE study
- Presence of dermatologic conditions and/or comorbidities that might confound the diagnosis of AD and/or interfere with study assessments Note...
The study team makes the final eligibility decision.
Where it is enrolling
- Fountain Valley, California, United States
- Los Angeles, California, United States
- Coral Gables, Florida, United States
- Jacksonville, Florida, United States
- Margate, Florida, United States
- Douglasville, Georgia, United States
- Skokie, Illinois, United States
- Bowling Green, Kentucky, United States
- Rockville, Maryland, United States
- Detroit, Michigan, United States
- Troy, Michigan, United States
- New York, New York, United States
- Wilmington, North Carolina, United States
- Boardman, Ohio, United States
- Mason, Ohio, United States
- Portland, Oregon, United States
- Pittsburgh, Pennsylvania, United States
- Charleston, South Carolina, United States
- Nashville, Tennessee, United States
- Dallas, Texas, United States
+ 54 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Fountain Valley, California, United States; Los Angeles, California, United States; Coral Gables, Florida, United States; Jacksonville, Florida, United States; Margate, Florida, United States; Douglasville, Georgia, United States and 68 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.